At a glance
- Originator Pharmacia Corporation
- Class Antihypertensives; Guanidines; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 17 Jul 1998 No-Development-Reported for Hypertension in USA (Unknown route)
- 05 Dec 1995 New profile
- 05 Dec 1995 Preclinical development for Hypertension in USA (Unknown route)